JudyLinnFelgenhauerMD

Pediatric Hematology & Oncology • Spokane, WA

Physician

Join to view full profile

Dr. Felgenhauer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Felgenhauer's full profile

Already have an account?

Office
101 W 8th Ave
Spokane, WA 99204
Phone+1 509-474-2777

Fax+1 509-474-6222
Is this information wrong?

Education & Training

University of WashingtonFellowship, Pediatric Hematology/Oncology, 1993 - 1996
University of WashingtonResidency, Pediatrics, 1990 - 1993
University of Washington School of MedicineClass of 1990

Certifications & Licensure

WA State Medical License 1982 - 2025
ID State Medical License 2005 - 2024
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Fellow (FAAP) American Academy of Pediatrics

Clinical Trials

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma Start of enrollment: 2001 Feb 01
Unknown status
Phase 3
Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
Active, not recruiting
Phase 3
Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma Start of enrollment: 2004 Mar 15
Completed
Phase 3
Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors Start of enrollment: 2004 Apr 01
Completed
Phase 2
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma Start of enrollment: 2004 Sep 04
Completed
Phase 3
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors Start of enrollment: 2004 Mar 25
Recruiting
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma Start of enrollment: 2004 Apr 01
Active, not recruiting
Phase 3
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma Start of enrollment: 2005 Nov 14
Completed
Phase 3
Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission Start of enrollment: 2005 May 30
Completed
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer Start of enrollment: 2006 Feb 20
Completed
Phase 3
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors Start of enrollment: 2006 Jun 01
Completed
Phase 2
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor Start of enrollment: 2006 Oct 30
Active, not recruiting
Phase 3
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma Start of enrollment: 2006 Dec 26
Completed
Phase 3
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Start of enrollment: 2007 Mar 01
Completed
Phase 1, Phase 2
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor Start of enrollment: 2007 Feb 26
Active, not recruiting
Phase 3
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia Start of enrollment: 2007 Mar 01
Completed
Phase 3
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Start of enrollment: 2007 Mar 26
Active, not recruiting
Phase 3
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Start of enrollment: 2007 Jan 22
Active, not recruiting
Phase 3
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia Start of enrollment: 2007 Jan 01
Completed
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin Start of enrollment: 2007 May 01
Completed
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2008 Jan 15
Active, not recruiting
Phase 3
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy Start of enrollment: 2008 Jun 23
Completed
Phase 3
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies Start of enrollment: 2008 Jul 17
Recruiting
Neuropsychological and Behavioral Testing in Younger Patients With Cancer Start of enrollment: 2009 Feb 27
Recruiting
Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors Start of enrollment: 2009 Jan 01
Completed
Phase 2
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Start of enrollment: 2009 Mar 01
Completed
Phase 2
Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma Start of enrollment: 2006 Sep 25
Completed
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Oct 13
Completed
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
Recruiting
Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma Start of enrollment: 2008 Feb 04
Completed
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04
Completed
Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma Start of enrollment: 2006 Oct 23
Completed
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
Completed
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors Start of enrollment: 2004 Feb 16
Completed
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor Start of enrollment: 2009 Jul 13
Active, not recruiting
Phase 3
Study of Blood Samples From Newborns With Down Syndrome Start of enrollment: 2009 Feb 23
Completed
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma Start of enrollment: 2005 May 30
Completed
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma Start of enrollment: 2010 Jan 01
Completed
Phase 2
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Start of enrollment: 2010 May 07
Active, not recruiting
Phase 3
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia Start of enrollment: 2011 Feb 01
Completed
Phase 2
Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin Start of enrollment: 2010 Oct 04
Active, not recruiting
Phase 1
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
Active, not recruiting
Phase 3
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Start of enrollment: 2010 Nov 22
Completed
Phase 2
Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma Start of enrollment: 2010 Oct 01
Completed
Phase 2
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
Active, not recruiting
Phase 3
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Start of enrollment: 2011 Apr 04
Completed
Phase 3
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Jun 20
Active, not recruiting
Phase 3
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum Start of enrollment: 2012 Feb 01
Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission Start of enrollment: 2012 Feb 21
Active, not recruiting
Phase 3
Intergroup Trial for Children or Adolescents With B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients Start of enrollment: 2012 Jun 01
Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma Start of enrollment: 2013 Feb 12
Completed
Phase 2
Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant Start of enrollment: 2013 Nov 04
Completed
Phase 3
Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma Start of enrollment: 2014 Oct 04
Active, not recruiting
Phase 3
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01
Comparison of Ideal vs. Actual Weight Base Factor Dosing Start of enrollment: 2017 Jan 01
Unknown status
Not Applicable
Roles: Contact
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis Start of enrollment: 2016 Nov 02
Recruiting
Phase 2, Phase 3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

1 citations
Dabigatran in the treatment and secondary prophylaxis of venous thromboembolism in children with thrombophilia.
Leonardo R Brandão, Igor Tartakovsky, Manuela Albisetti, Jacqueline Halton, Lisa Bomgaars, Elizabeth Chalmers, Matteo Luciani, Paola Saracco, Judy Felgenhauer, Olga Lv...> ;Blood Advances. 2022 Nov 22
58 citations
Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial.
Jacqueline Halton, Leonardo R. Brandão, Matteo Luciani, Lisa Bomgaars, Elizabeth Chalmers, Lesley G. Mitchell, Ildar Nurmeev, Anjali Sharathkumar, Pavel Svirin, Kirill...> ;The Lancet. Haematology. 2021 Jan 1
5 citations
Navigating your career path in pediatric hematology/oncology: On and off the beaten track
Patrick A. Zweidler-McKay, Mary Jane Staba Hogan, Rima Jubran, Vandy Black, Jacqueline Casillas, James Harper, Suman Malempati, Judith F. Margolin, Judy Felgenhauer, K...> ;Pediatric Blood & Cancer. 2016 Oct 1
18 citations
Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Repo...
Leo Mascarenhas, Judy Felgenhauer, Mason Bond, Doojduen Villaluna, Joseph D. Femino, Nadia N. Laack, Sarangarajan Ranganathan, James S. Meyer, Richard B. Womer, Richar...> ;Pediatric Blood & Cancer. 2016 Mar 1
34 citations
Identification of Discrete Prognostic Groups in Ewing Sarcoma
Erin E. Karski, Elizabeth McIlvaine, Mark R. Segal, Mark Krailo, Holcombe E. Grier, Linda Granowetter, Richard B. Womer, Paul A. Meyers, Judy Felgenhauer, Neyssa Marin...> ;Pediatric Blood & Cancer. 2016 Jan 1
17 citations
Regulatory barriers to clinical trial enrollment of adolescent and young adult oncology patients.
Judy Felgenhauer, Mary C. Hooke> ;Pediatrics. 2014 Jun 1
45 citations
A pilot study of low‐dose anti‐angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma ...
Judy Felgenhauer, Michael Nieder, Mark Krailo, Mark L. Bernstein, David W. Henry, David Malkin, Sylvain Baruchel, Paul J. Chuba, Scott L. Sailer, Ken Brown, Sarangaraj...> ;Pediatric Blood & Cancer. 2013 Mar 1
46 citations
Children's Oncology Group's 2013 blueprint for research: Adolescent and young adult oncology
David R. Freyer, Judy Felgenhauer, John P. Perentesis> ;Pediatric Blood & Cancer. 2013 Jun 1
15 citations
Increasing diversity in pediatric hematology/oncology.
Ernest Frugé, Joan M. Lakoski, Naomi L.C. Luban, Jeffrey M. Lipton, David G. Poplack, Anne Hagey, Judy Felgenhauer, Joanne M. Hilden, Judith F. Margolin, Sarah R. Vais...> ;Pediatric Blood & Cancer. 2011 Jul 15
5 citations
Localized purpura associated with lamotrigine.
Catherine Amlie-Lefond, Judy Felgenhauer, Alan D. Leong> ;Pediatric Neurology. 2006 Sep 1
9 citations
Infantile myofibromatosis of the posterior fossa.
Phillip R. Chapman, Corey D. Judd, Judy L. Felgenhauer, David P. Gruber, Dan Mornin> ;AJR. American Journal of Roentgenology. 2005 Apr 1
11 citations
Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse.
Blythe Thomson, Julie R. Park, Judy Felgenhauer, Soheil Meshinchi, John Holcenberg, J. Russell Geyer, Vassilios I. Avramis, James G. Douglas, Michael R. Loken, Douglas...> ;Pediatric Blood & Cancer. 2004 Oct 1
76 citations
Asparaginase Pharmacokinetics After Intensive Polyethylene Glycol-Conjugated L-Asparaginase Therapy for Children with Relapsed Acute Lymphoblastic Leukemia
Douglas S. Hawkins, Julie R. Park, Blythe Thomson, Judy Felgenhauer, John S. Holcenberg, Eduard H. Panosyan, Vassilios I. Avramis> ;Clinical Cancer Research. 2004 Aug 15
12 citations
Intensive induction chemotherapy and delayed irradiation in the management of parameningeal rhabdomyosarcoma.
Stephen C. Smith, Skyler K Lindsley, Judy Felgenhauer, Douglas S. Hawkins, James G. Douglas> ;Journal of Pediatric Hematology/oncology. 2003 Oct 1
25 citations
Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
Douglas S. Hawkins, Judy Felgenhauer, Julie Park, Susan Kreissman, Blythe Thomson, M.P.H. James Douglas M.D., Scott D. Rowley, Ted Gooley, Jean E. Sanders, M.S.P.H. Th...> ;Cancer. 2002 Sep 15
3 citations
No excess of early onset cancer in family members of Wilms tumor patients.
Judy L. Felgenhauer, M B A Jean Barce, L B A Roberta Benson, Bin Nan, Jane M. Olson, Norman E. Breslow> ;Cancer. 2001 Sep 15
23 citations
Successful dose-intensive treatment of desmoplastic small round cell tumor in three children
Peter Kurre, Judy Felgenhauer, James S. Miser, Kathleen Patterson, Douglas S. Hawkins> ;Journal of Pediatric Hematology/oncology. 2000 Sep 1
31 citations
Very intensive, short-term chemotherapy for children and adolescents with metastatic sarcomas.
Judy Felgenhauer, Douglas S. Hawkins, Thomas W. Pendergrass, Karen L. Lindsley, Ernest U. Conrad, James S. Miser> ;Medical and Pediatric Oncology. 2000 Jan 1
34 citations
Elevated zinc protoporphyrin associated with thalassemia trait and hemoglobin E
Elinor A. Graham, Judy Felgenhauer, James C. Detter, Robert F. Labbe> ;The Journal of Pediatrics. 1996 Jul 1
39 citations
Relationship Between Epidemiologic Risk Factors and Clinicopathologic Findings in the Sudden Infant Death Syndrome
Joel E. Haas, J. A. Taylor, A. B. Bergman, G. Van Belle, Judy Felgenhauer, Joseph R. Siebert, D. R. Benjamin> ;Pediatrics. 1993 Jan 1
RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing''s sarcoma and ...
Thomson, B., Hawkins, D., Felgenhauer, J., Radich, J.> ;Bone Marrow Transplant. 1999 Sep
Join now to see all

Professional Memberships

American Academy of Pediatrics - AAP
Fellow

Hospital Affiliations

Providence Sacred Heart Medical Center & Children's HospitalSpokane, Washington

JudyLinnFelgenhauerMD

Dr. Felgenhauer is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Professional Memberships

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.